Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

NCT00000626 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Hodgkin's Disease

Interventions

DRUG: Vinblastine sulfate
DRUG: Dacarbazine
DRUG: Filgrastim
DRUG: Bleomycin sulfate
DRUG: Doxorubicin hydrochloride

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]